The global demand for the diagnosis and treatment of meningitis is influenced largely by the growing demand for products with high clinical efficacy for treating chronic disorders. Increase in the implementation of new drug delivery mechanisms for the treatment of diseases, increase in technical advancements, and increase in public-private investments to promote the development of novel drugs is likely to favour the market growth. Additionally, extension of research efforts to assess the therapeutic effectiveness of cell encapsulation technology is predicted to increase the technology penetration across the globe. However, the insufficient supply of high-quality raw materials, the inflated cost of production and the surge in the use of alternative treatments are likely to hamper the growth of the global market.
North America is projected to dominate the global industry, owing to a rise in clinical research on the effectiveness of cell encapsulation techniques and an increase in medical professionals' acceptance of cell encapsulation techniques. In addition, the growth in cell encapsulation research activities and the increase in public and private healthcare investments are increasing the demand for live cell encapsulation in North America. During the forecast era, the Asia Pacific market is expected to develop strongly due to an increase in R&D operations, an increase in government initiatives to improve health care, and an increase in the emphasis of key players on strengthening their role in the region.
Adroit Market Research study on the global market for live cell encapsulation offers a holistic view of the industry from 2020 to 2028 as forecast period, including factors such as market drivers, limitations, opportunities, threats and regulatory overview. The market has been analyzed from 2018 to 2028, with a base year estimate of 2019 and a projection from 2020 to 2028. The report covers the current status and potential characteristics of the market at both the global and the country level. Moreover, the report also assesses market competition with Porter's analysis of five strengths and places leading players on the basis of their product range, regional presence, strategic initiatives and overall sales. Prominent players in the global composite resin market have been analyzed in depth.
Key vendors in the market include Altucell, Inc, Viacyte, Inc., BÜCHI Labortechnik AG, Sigilon Therapeutics, Inc.,Blacktrace Holdings Ltd,, Evonik Industries,Neurotech Pharmaceuticals, Inc., Living Cell Technologies Ltd.,Gloriana Therapeutics, Kadimastem, Sernova CorporationBeta-O2 Technologies, Inc.,BioTime, Inc. , and Defymed.
Key Segments of the Global live cell encapsulation Market
Manufacturing Technique Overview, 2018-2028 (USD Million)
- Simple Dripping
- Electrostatic Dripping
- Liquid Jet Break Up
- Coaxial Airflow
- Vibrating Jet
- Jet Cutting
- Rotating Disk Atomization
Polymer Type Overview, 2018-2028 (USD Million)
- Alginate
- HEMA-MMA
- Chitosan
- Siliceous Encapsulates
- Cellulose Sulfate
- PAN-PVC
- Other Polymers
Application Overview, 2018-2028 (USD Million)
- Drug Delivery
- Regenerative medicine
- Cell Transplantation
- Probiotics
- Research
Regional Overview, 2018-2028 (USD Million)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Middle East and Africa
- UAE
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Rest of South America